I saw an article saying something like this but it was just the Civica announces Semglee rebranded as Civica and CalRx $55 ÷ 5 pens = $11/pen. The announcements of the rebranding deal said nothing about suggesting pricing of a single pen or even if single pens could be sold. The rebranded Semglee will be available nationwide. California isn’t producing this Lantus biosimilar and the project the state is funding, the Novolog biosimilar, hasn’t even made it to phase 1 clinical trials yet.
